May 17, 2022
A Connecticut attorney argued that a judge's admittedly "inexcusable" error in not polling the jury following a verdict in his U.S. Securities and Exchange Commission fraud trial should result in the verdict being tossed, making his case to a new jurist Tuesday after the first recused himself.
May 11, 2022
A Connecticut attorney said Tuesday a Boston jury's finding that he ran a securities fraud scheme must be vacated due to thin trial evidence, prejudicial testimony and the court's faulty jury instructions.
April 21, 2022
A Boston federal judge on Thursday acknowledged making an "inexcusable mistake" in refusing to poll a jury that found a Connecticut lawyer liable for securities fraud and recused himself from hearing the attorney's bid for a new trial.
April 18, 2022
A Connecticut lawyer found liable for a complex stock scheme shouldn't get a new trial based on his attorney's "secondhand" reports of disagreement in the jury deliberation room and a judge's refusal to poll the panel, the U.S. Securities and Exchange Commission argued Monday.
April 06, 2022
A Connecticut attorney argued Wednesday that a jury verdict finding him liable for running a complex stock scheme may not have been unanimous, and he should get a new trial because the presiding judge did not poll the panel.
April 04, 2022
A Boston federal jury on Monday found that a Connecticut lawyer fraudulently dodged securities rules through a complex corporate scheme that earned him a windfall when he merged his money-losing yoga studio business with a startup biotech firm.
March 22, 2022
A "smart, savvy" Connecticut attorney used friends, family and others to dodge securities rules when he spun a money-losing yoga studio onto the public stock market and made himself a windfall by merging the business with a startup biotech firm, a Boston federal jury heard Tuesday.
March 10, 2022
A Massachusetts federal judge has affirmed his previous finding that a Connecticut attorney accused of illegally selling shares of biotech company PixarBio was liable for evading the registration requirements for selling securities, handing the U.S. Securities and Exchange Commission an early win on a claim in the case.
January 13, 2022
A Boston federal judge on Thursday agreed with the U.S. Securities and Exchange Commission that a Connecticut attorney illegally sold shares of biotech company PixarBio, handing the agency a partial pretrial win in a case that has ensnared other lawyers and executives.
July 30, 2020
Two disbarred New York attorneys have agreed to pay $29,000 to end the U.S. Securities and Exchange Commission's suit accusing them of facilitating a sham merger involving biotech PixarBio, according to a consent motion filed Thursday in Massachusetts federal court.